Detalhe da pesquisa
1.
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
Am J Pathol
; 189(5): 1077-1090, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30794805
2.
The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans.
Hepatology
; 70(5): 1600-1613, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31062368
3.
Functional role of SGK3 in PI3K/Pten driven liver tumor development.
BMC Cancer
; 19(1): 343, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975125
4.
Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.
Medicina (Kaunas)
; 55(6)2019 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31234428
5.
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.
Hepatology
; 66(1): 167-181, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370287
6.
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice.
J Hepatol
; 67(6): 1194-1203, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28733220
7.
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
J Hepatol
; 64(2): 333-341, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26476289
8.
Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison.
Biochim Biophys Acta
; 1826(1): 215-37, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23393659
9.
Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
J Hepatol
; 59(4): 830-41, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23665184
10.
Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Hepatology
; 56(1): 165-75, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22318685
11.
The complex role of bone morphogenetic protein 9 in liver damage and regeneration: New evidence from in vivo and in vitro studies.
Liver Int
; 38(9): 1547-1549, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30145848
12.
An infernal cross-talk between oncogenic ß-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling.
Hepatology
; 64(5): 1421-1423, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27596836
13.
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
Hepatology
; 53(4): 1226-36, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21480327
14.
Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation.
Hepatology
; 54(6): 2149-58, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21800344
15.
Genetic Predisposition to Hepatocellular Carcinoma.
Metabolites
; 13(1)2022 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36676960
16.
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.
Cells
; 11(3)2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35159219
17.
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase.
Transl Oncol
; 15(1): 101239, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649149
18.
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
J Hepatol
; 55(1): 111-9, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21419759
19.
Blood Cell Count Indexes of Systemic Inflammation in Carotid Artery Disease: Current Evidence and Future Perspectives.
Curr Pharm Des
; 27(18): 2170-2179, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355049
20.
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease.
Int J Cancer
; 126(5): 1275-81, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19533683